Literature DB >> 8174959

Influence of preoperative radiotherapy on DNA ploidy in squamous cell carcinomas of the oesophagus.

R Porschen1, G Bevers, U Remy, S Schauseil, F Borchard.   

Abstract

The influence of preoperative radiotherapy on the prevalence of DNA aneuploidy and the prognostic significance of tumour DNA ploidy was evaluated in 126 patients with squamous cell carcinoma of the oesophagus. Preoperative radiotherapy with 30 Gy was performed in 52 patients. DNA ploidy was analysed by flow cytometry on nuclei isolated from paraffin embedded tumour tissue. DNA aneuploidy was identified in 75 tumours (61%) and found to correlate significantly with tumour stage. The percentage of aneuploid carcinomas was significantly reduced by preoperative radiotherapy (surgery only group, 71%; radiotherapy group, 47%, p = 0.01). Although the median survival time was slightly better in the diploid than in the aneuploid group (11.3 and 8.0 months respectively), this difference was not statistically significant. A curative tumour resection was the most important prognostic factor. Preoperative radiotherapy did not prolong survival in oesophageal cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8174959      PMCID: PMC1374359          DOI: 10.1136/gut.34.8.1086

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Flow cytometric DNA analysis of squamous cell carcinoma of the esophagus.

Authors:  A Ruol; A Segalin; M Panozzo; J K Stephens; P Dalla Palma; D B Skinner; A Peracchia; A G Little
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

2.  The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C.

Authors:  M Gignoux; A Roussel; B Paillot; M Gillet; P Schlag; J P Favre; O Dalesio; M Buyse; N Duez
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

3.  Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.

Authors:  Y Yonemura; S Ooyama; K Sugiyama; T Kamata; X De Aretxabala; H Kimura; T Kosaka; A Yamaguchi; K Miwa; I Miyazaki
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

4.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

5.  Flow-cytometric DNA content analysis of esophageal squamous cell carcinomas.

Authors:  M Robaszkiewicz; B J Reid; A Volant; J M Cauvin; P S Rabinovitch; H Gouerou
Journal:  Gastroenterology       Date:  1991-12       Impact factor: 22.682

6.  Cytophotometric DNA analysis of mucosal and submucosal carcinoma of the esophagus.

Authors:  K Sugimachi; H Ide; T Okamura; H Matsuura; M Endo; K Inokuchi
Journal:  Cancer       Date:  1984-06-15       Impact factor: 6.860

7.  Flow cytometric analysis of nuclear DNA content in esophageal cancer. Aneuploidy as an index for highly malignant potential.

Authors:  K Kaketani; T Saito; M Kobayashi
Journal:  Cancer       Date:  1989-08-15       Impact factor: 6.860

8.  Predicting local recurrence of carcinoma of the rectum after preoperative radiotherapy and surgery.

Authors:  D J Jones; J Zaloudik; R D James; N Haboubi; M Moore; P F Schofield
Journal:  Br J Surg       Date:  1989-11       Impact factor: 6.939

9.  Flow cytofluorometric evidence for the differential radioresponsiveness of aneuploid and diploid cervix tumours.

Authors:  J E Dyson; C A Joslin; R I Rothwell; P Quirke; G G Khoury; C C Bird
Journal:  Radiother Oncol       Date:  1987-03       Impact factor: 6.280

10.  The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis.

Authors:  N C Armitage; K C Ballantyne; D F Evans; P Clarke; J Sheffield; J D Hardcastle
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

View more
  1 in total

1.  Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.

Authors:  K Dolan; J Garde; J Gosney; M Sissons; T Wright; A N Kingsnorth; S J Walker; R Sutton; S J Meltzer; J K Field
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.